Log In
BCIQ
Print this Print this
 

Pivlaz, clazosentan

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionEndothelin A receptor antagonist
Molecular Target Endothelin A receptor
Mechanism of ActionEndothelin A receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAneurysm
Indication DetailsReversal of vasospasm associated with aneurysmal subarachnoid hemorrhage (aSAH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today